Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Basedow Disease

cetylpyridinium chloride anhydrous has been researched along with Basedow Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abraham-Nordling, M; Calissendorff, J; Hamberger, B; Lundell, G; Tallstedt, L; Törring, O; Wallin, G1

Trials

1 trial(s) available for cetylpyridinium chloride anhydrous and Basedow Disease

ArticleYear
Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery.
    Thyroid : official journal of the American Thyroid Association, 2005, Volume: 15, Issue:11

    Topics: Adult; Aging; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Health; Humans; Iodine Radioisotopes; Male; Mental Health; Middle Aged; Quality of Life; Recurrence; Social Behavior; Surveys and Questionnaires; Sweden; Thyroidectomy; Thyrotropin

2005